Literature DB >> 16131068

Liquid-phase binding assay of alpha-fetoprotein using DNA-coupled antibody and capillary chip electrophoresis.

Tomohisa Kawabata1, Mitsuo Watanabe, Kenji Nakamura, Shinji Satomura.   

Abstract

An immunoassay using DNA-coupled antibody for bound/free separation in a liquid-phase binding assay format is described. Anti-alpha-fetoprotein monoclonal antibody was conjugated with DNA, mixed with alpha-fetoprotein (AFP), and incubated, and then 1 muL of the mixture was applied to capillary electrophoresis on a microchip. The DNA molecule of the antibody-DNA conjugate and the DNA-conjugated immune complex peak were detectable fluorophotometrically using intercalator dye within 90 s, whereas the Alexa-labeled antibody was detected as a broad and slower migrating peak. The electrophoretic mobility of the immune complex could be optimized for resolution and sharpness by changing the length of the DNA coupled to the antibody. The detection limit of AFP was approximately 300 pM in a sample. This immunoassay method utilizing a liquid-phase binding assay format is simple and convenient for antigen measurements on microchips.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131068     DOI: 10.1021/ac050458p

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  3 in total

1.  Integrated microfluidic device for serum biomarker quantitation using either standard addition or a calibration curve.

Authors:  Weichun Yang; Xiuhua Sun; Hsiang-Yu Wang; Adam T Woolley
Journal:  Anal Chem       Date:  2009-10-01       Impact factor: 6.986

2.  An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.

Authors:  Tomokazu Ishikawa; Tohru Yoneyama; Yuki Tobisawa; Shingo Hatakeyama; Tatsuo Kurosawa; Kenji Nakamura; Shintaro Narita; Koji Mitsuzuka; Wilhelmina Duivenvoorden; Jehonathan H Pinthus; Yasuhiro Hashimoto; Takuya Koie; Tomonori Habuchi; Yoichi Arai; Chikara Ohyama
Journal:  Int J Mol Sci       Date:  2017-02-22       Impact factor: 5.923

3.  ExoHCR: a sensitive assay to profile PD-L1 level on tumor exosomes for immunotherapeutic prognosis.

Authors:  Lujun Hu; Wenjie Chen; Shurong Zhou; Guizhi Zhu
Journal:  Biophys Rep       Date:  2020-11-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.